Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Conditions

• Metastatic Breast Cancer
• Metastatic Prostate Cancer

Interventions

• OTHER: Morning administration of CDK4/6 inhibitor
• OTHER: Evening administration of CDK4/6 inhibitor
• OTHER: Morning administration of ARPI
• OTHER: Evening administration of ARPI

Sponsor

Ottawa Hospital Research Institute